The genetic association between Cathepsin D and Alzheimer's disease
Authors:
- M.J FreemanMFM.J Freeman
- M.J MullanMMM.J Mullan
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in Neuroscience Letters
- Vol. 289 (1) , 61-65
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Novel Cathepsin D Inhibitors Block the Formation of Hyperphosphorylated Tau Fragments in HippocampusJournal of Neurochemistry, 2000
- Identification of β-secretase-like activity using a mass spectrometry-based assay systemNature Biotechnology, 2000
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- Cathepsin D displays in vitro β-secretase-like specificityBrain Research, 1997
- A β‐amyloid peptide variant related with familial Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis is poorly eliminated by cathepsin DFEBS Letters, 1996
- Evaluation of Cathepsins D and G and EC 3.4.24.15 as Candidate β‐Secretase Proteases Using Peptide and Amyloid Precursor Protein SubstratesJournal of Neurochemistry, 1996
- Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's diseaseJournal of the Neurological Sciences, 1995
- Candidate .gamma.-Secretases in the Generation of the Carboxyl Terminus of the Alzheimer's Disease .beta.A4 Amyloid: Possible Involvement of Cathepsin DBiochemistry, 1995
- Apolipoprotein E4 allele frequency in Spanish Alzheimer and control casesNeuroscience Letters, 1995
- Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal systemNeuron, 1995